PURPOSE: Although thrombocytosis has been reported in patients with various cancers including the colorectal one, the impact of elevated platelet counts on the response to chemoradiotherapy (CRT) for rectal cancer has not been fully investigated. We investigated the clinical significance of pre- and post-CRT platelet counts in patients with rectal cancer. METHODS: The medical records of 101 patients with rectal cancer, who had received CRT followed by surgical resection, were retrospectively reviewed. The correlations between the clinicopathological variables and the pre- or post-CRT platelet counts were analyzed. The correlations between tumor regression rate induced by CRT, as evaluated by barium enema and pathological examination, and the pre- or post-CRT platelet counts were also evaluated. Finally, the impact of pre-CRT thrombocytosis on the prognosis of these patients was assessed. RESULTS: The pre-CRT platelet count correlated with venous invasion and tumor size, and it strongly correlated with the response rate evaluated by barium enema and the grade of pathological tumor regression. Furthermore, patients with pre-CRT thrombocytosis had significantly shorter local recurrence-free survival. CONCLUSION: Platelet count before CRT should be a promising biomarker for predicting the efficacy of CRT and the risk of local recurrence in rectal cancer patients after CRT.
PURPOSE: Although thrombocytosis has been reported in patients with various cancers including the colorectal one, the impact of elevated platelet counts on the response to chemoradiotherapy (CRT) for rectal cancer has not been fully investigated. We investigated the clinical significance of pre- and post-CRT platelet counts in patients with rectal cancer. METHODS: The medical records of 101 patients with rectal cancer, who had received CRT followed by surgical resection, were retrospectively reviewed. The correlations between the clinicopathological variables and the pre- or post-CRT platelet counts were analyzed. The correlations between tumor regression rate induced by CRT, as evaluated by barium enema and pathological examination, and the pre- or post-CRT platelet counts were also evaluated. Finally, the impact of pre-CRT thrombocytosis on the prognosis of these patients was assessed. RESULTS: The pre-CRT platelet count correlated with venous invasion and tumor size, and it strongly correlated with the response rate evaluated by barium enema and the grade of pathological tumor regression. Furthermore, patients with pre-CRT thrombocytosis had significantly shorter local recurrence-free survival. CONCLUSION: Platelet count before CRT should be a promising biomarker for predicting the efficacy of CRT and the risk of local recurrence in rectal cancerpatients after CRT.
Authors: C G Fu; O Tominaga; H Nagawa; M E Nita; T Masaki; G Ishimaru; Y Higuchi; T Tsuruo; T Muto Journal: Dis Colon Rectum Date: 1998-01 Impact factor: 4.585
Authors: Mohit Trikha; Zhao Zhou; Jozsef Timar; Erzebet Raso; Margaret Kennel; Eva Emmell; Marian T Nakada Journal: Cancer Res Date: 2002-05-15 Impact factor: 12.701
Authors: A Piccioli; A W A Lensing; M H Prins; A Falanga; G L Scannapieco; M Ieran; M Cigolini; G B Ambrosio; M Monreal; A Girolami; P Prandoni Journal: J Thromb Haemost Date: 2004-06 Impact factor: 5.824
Authors: Miroslav Hodek; Igor Sirák; Alexander Ferko; Július Örhalmi; Eva Hovorková; Dimitar Hadži Nikolov; Petr Paluska; Jindřich Kopecký; Jiří Petera; Milan Vošmik Journal: Strahlenther Onkol Date: 2016-06-06 Impact factor: 3.621
Authors: Angelo Restivo; Ivana Maria Francesca Cocco; Giuseppe Casula; Francesco Scintu; Francesco Cabras; Mario Scartozzi; Luigi Zorcolo Journal: Br J Cancer Date: 2015-09-15 Impact factor: 7.640